key: cord-1015669-s98xdfwr authors: Gardener, A. D.; Hicks, E. J.; Jacklin, C.; Tan, G.; Cashin, A. G.; Lee, H.; Nunan, D.; Toomey, E. C.; Richards, G. C. title: Open science policies of medical and health sciences journals before and during the COVID-19 pandemic: a repeat cross-sectional study date: 2022-01-28 journal: nan DOI: 10.1101/2022.01.26.22269868 sha: 7cef3fcf43ba520d899e4ab685abc3200ad32ea4 doc_id: 1015669 cord_uid: s98xdfwr Cross-disciplinary openness and transparency of research plays an important role in scientific progress. We evaluated open-science related policies of 19 high ranking health and medical journals before (February 2020) and during (May 2021) the COVID-19 pandemic. The Transparency and Openness Promotion (TOP) guideline and the International Committee of Medical Journal Editors (ICMJE) requirements for disclosing conflicts of interest (COIs) were used to audit journal policies. TOP scores slightly improved during the COVID-19 pandemic, from a median of 5 (IQR: 2-12.5) out of a possible 24 points in February 2020 to 7 (IQR: 4-12) in May 2021. Most journals fulfilled all ICMJE provisions for reporting COIs before (84%; n=16) and during (95%; n=18) the COVID-19 pandemic. The COVID-19 pandemic has highlighted the importance of practising open science, however adherence to open science standards in audited policies was low overall, which may reduce progress in health and medical research. Scientific advancement in any field or discipline relies considerably on transparent research practices 1 . This includes medicine and public health. The ability to access, evaluate, and extrapolate the findings from research to clinical practice and policy relies on the transparency of available evidence 1, 2 . Research transparency is also imperative for the replication of scientific findings 1 3, 4 . Open science is defined as research activities and outputs that are made publically available with little to no restrictions 5 . Open and transparent practices include, but are not limited to, the preregistration of study protocols and analysis plans, the sharing of data, statistical code, and research materials, and the disclosure of authors' conflicts of interests. Making code and data openly available allows for reuse, replication, and peer assessment, which is an important step in verifying the findings of studies and progressing science 6 . Poor adherence to open practices produces unreliable outcomes and slows scientific progress [7] [8] [9] . Research published during the COVID-19 pandemic has highlighted the widespread impact of practising 'closed' research, where cases of undisclosed data and a lack of transparency led to high-profile retractions 10, 11 . This can compromise public trust, sway public opinions and policies, and bias future research 12 . The pandemic has also demonstrated the positive impacts of open sciences practices, as demonstrated by quick data sharing used to identify the COVID-19 genome rapidly and journals removing . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint paywalls for COVID-19 research, resulting in more equitable and widespread access to research 13-15 . There are various tools available to support and reward the practice of open science, including freely available repositories (e.g. GitHub, Figshare) and platforms (e.g. the Open Science Framework [OSF]), publication methods (e.g. registered reports), and open science badges [16] [17] [18] [19] . However, some researchers have expressed concerns regarding practising openly, including but not limited to one's intellectual property not being cited or acknowledged correctly, losing a competitive advantage to groups working on similar research, practicality concerns, and patient confidentiality 20, 21 . Other factors that are likely to contribute to poor adherence include a lack of knowledge or skills in using these tools to facilitate openness and the flawed incentive system that encourages the publication of more instead of better research 22, 23 28 . Since the publication of the TOP guideline, several evaluations of journal policies using the TOP guidelines have been published [29] [30] [31] , which suggest poor compliance to TOP guideline standards across multiple fields of research. Since the beginning of the COVID-19 pandemic, several journals have released statements and made efforts to improve the openness and transparency of COVID-19 research to support researchers during the pandemic 32, 33 . To date, a peer-reviewed evaluation of high-ranking general medical and health science journals assessing open science practices before or during the COVID-19 pandemic has not been conducted. Therefore, we aimed to conduct this evaluation and explore the potential impact of the COVID-19 pandemic on the adherence to transparent and open science standards of leading health and medical journals. We designed a cross-sectional study based on methods developed by Cashin et al. 29 and preregistered the study protocol on the OSF 34 . We completed the first policy audit in early 2020 and repeated the same audit in 2021 to assess the potential impact of the COVID-19 pandemic on journal policies. We used the TOP guideline to audit and score each journal's policy. All audits were performed in duplicate by two independent study authors (ADG, EH, CJ, GT, AGC, HL, DN, ET), and discrepancies were adjudicated with a third author (GCR). The TOP guideline has eight standards: data citation, data transparency, code transparency, materials transparency, design and analysis transparency, study preregistration, analysis preregistration, and replication 27, 37 . For scoring, we used version 1 of the TOP rubric 38 , where 0 (zero) denotes "no mention" (of the standard in the policy wording), 1 "discloses", 2 "requires", and 3 "verifies". The maximum score obtainable for TOP was 24. Justifications for scoring, along with quoted material from the journal policy, where appropriate, are provided in the Google Sheet master files on our OSF repository 36 . Where a policy demonstrated varying requirements (for example, different types of study design) or only mentioned requirements for one element (for example, requiring the use of reporting guidelines or study preregistration for clinical trials only), a score was given based on the lowest-scoring element in accordance with the TOP guidelines. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint Journals and funders can choose to become signatories of TOP to express their support, interest, and commitment in adopting such standards 37 . Hence we also scored the included journals on whether they were a signatory of TOP, permitted registered reports, and used open science badges. For these metrics, we provided scores based on previously published methods (i.e. TOP signatory: no=0, yes=1; registered reports: no=0, yes=2; and open science badges: no=0, yes=2) 29 . To examine the journal's requirements for authors to disclose conflict of interests (COIs), we used the four standards in the International Committee of Medical Journal Editors (ICMJE) disclosure form 39 . The four standards include: 1) recipient of payment or services from a third party (government, commercial, private foundation) for any aspect of the submitted work; 2) any financial relationships (regardless of the amount of compensation) with entities in the biomedical arena that could be perceived to influence, or that give the appearance of influencing, the submitted work; 3) any patents, whether planned, pending or issued, broadly relevant to the submitted work; and 4) any other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, the submitted work. We scored the journal policies for disclosing COIs on a 0 to 4 scale, with 0 being no statement of any of the standards and four being all standards or provision of the complete ICMJE disclosure form in accordance with published methods. 24 All scores were provided in separate Google Sheets that were combined, compared, and converted to a .csv file for analysis. We used descriptive statistics and calculated medians and interquartile ranges (IQRs) of scores where appropriate. Journals were ranked by their scores for the eight TOP standards (out of 24) and requirements for . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint COIs (out of 4). To assess where journals engaged most with TOP standards, we summed scores across journals for each TOP standard, where the maximum total could be 57 (3 possible points for 19 journals). Scores were compared before and during the COVID-19 pandemic using absolute values and percentage changes. We used pandas, seaborn, and matplotlib modules in Jupyter Notebooks with Python v3.7 to analyze the scores and create figures. Our study materials, data, code, and figures are openly accessible on our OSF repository 36 and GitHub 40 . In the protocol, we planned to examine the 20 journals listed in Google Scholar's Top Publications for health and medical sciences as listed on the search date (31 January 2020). We excluded the Cochrane Database of Systematic Reviews during analysis as it is a specialized journal that commissions research groups to adhere to a prescriptive methodology and differs significantly from the other included journals. Therefore, our study includes 19 journals. We preregistered a follow-up study to assess the impact of informing journals of their TOP scores in March 2020 41 . However, this second study was not conducted owing to the onset of the COVID-19 pandemic and the priority for journals to review and disseminate pressing COVID-19 related research. Instead, we repeated our evaluation in May 2021 to assess the adherence to the TOP guidelines during the COVID-19 pandemic, but did not pre-register the plans for this follow-up evaluation. For the eight TOP standards, journals had a median score of 5 (IQR: 2-12.5) out of a possible maximum score of 24 before the COVID-19 pandemic (February 2020), which . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. Eleven journals (58%) had no change in their TOP score following the onset of the COVID-19 pandemic. One-quarter of journals (26%, n=5) improved their policies; Gasterenrology had the greatest improvement (from a score of 2 to a score of 9), followed by the European Heart Journal (score of 0 to a score of 5), with the remaining three journals improving by a score of 2 (The Lancet, The Lancet Oncology, and PLoS ONE). Two journals, Cell and Neuron, had a reduction in their TOP score during the COVID-19 pandemic (Figure 1 ). . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint 13 Table 1 : Scores for the journal policies of 19 health and medical sciences journals using the Transparency and Openness Promotion (TOP) guideline before the COVID-19 pandemic (February 2020) and during (May 2021), ordered alphabetically by Journal. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. share their data, code, and study materials. The median ICMJE score of reporting COIs was 4 (IQR: 4-4) at both time points. Before the COVID-19 pandemic (February 2020), 84% (16/19) of journals fulfilled all four ICMJE standards for reporting COIs (Figure 3 ). In May 2021, this increased to 95% (18/19) . Cell was the only journal that did not fulfil the fourth ICMJE criteria across both time periods, which requires authors to report "any other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, the submitted work." . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint The transparency and openness standards in the policies of high-ranking health and medical sciences journals were low before and during the COVID-19 pandemic. We found limited improvement in open science standards between evaluations, with most (58%) journals making no change to their policies. The preregistration of study protocols and analysis plans and encouraging replication studies were the standards in most need of improvement. In May 2021, ten journals were signatories of the TOP guidelines, with PNAS signing after the first evaluation. PLoS One was the only journal to accept registered reports, and open science badges were not used by any journals. The majority of journals endorsed ICMJE standards for disclosing COIs. A lack of transparency in journal policies has been found across biomedical specialties 1 . Low engagement with transparent and open science standards in journal policies have been documented in research using the TOP guidelines to assess pain journals, sports science journals, and sleep and chronobiology journals. Those studies similarly found a limited requirement for authors to preregister their studies or analytic plans, and no journals assessed encouraged replication studies [29] [30] [31] . Incentives can improve engagement with transparency and openness standards 43 . Adopting open science badges may provide a valuable incentive for scientists to practice openly 43 . In a study by Kidwell et al., the authors found that four prominent psychology journals had less than 3% of articles reporting publicly accessible data before introducing open science badges. After these journals adopted open science badges, the same journals had nearly 40% of articles reporting publically accessible data 43 . Cashin et al. 29 and Spitschan et al. 30 found that no journal they assessed mentioned the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. TOP scores could be used to encourage journals to improve their policies. Researchers may be incentivized to submit their studies to journals that have high TOP scores, and the public may have more trust for research from such journals. However, this would require consensus for using such a metric. The journal Epidemiology declined to sign TOP with concerns that there was a lack of evaluation or revision over time, a 'one-size' application, and a disproportionate weight on the reproducibility of a finding compared with the accuracy of the research 45 . Furthermore, there is a risk of journals having variable degrees of compliance with TOP guidance in practice, as demonstrated by Goldacre et al., who found extensive breaches to CONSORT guidelines that journals endorsed in their policies 46 . These concerns could be ameliorated by COS regularly reviewing journals' promotion and concomitant adherence to the TOP guideline and by reviewing the wording of its guideline to ensure that it may be applied to a wider range of publication types. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. Due to the multitude of factors that may contribute to a journal's decision to change its policies, it is difficult to determine which improvements are a direct result of the COVID-19 pandemic. While the TOP guideline is a valuable tool for assessing journals' transparency and openness standards, there are some limitations. Firstly, the presence of imprecise and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint undefined terms when describing the required degree of adherence to a standard, such as 'should', 'strongly encourage', 'recommend' or 'expect', can lead to difficulties in allocating scores. To mitigate this, we conducted the scoring independently in dual and discussed scoring with a third study author to resolve differences in scoring. Our study assessed the policies of journals and not adherence of their published articles to these policies. The TOP guideline may not be applicable or flexible when examining the policies of specialized journals, such as the Cochrane Database of Systematic Reviews, which we excluded from our study. Nevertheless, the TOP guideline applies equally to journals that publish all study designs and provides a useful overview of how journals can improve the quality of research it publishes. Our methods can be replicated by others to assess the transparency and openness standards of journals in different research fields. This information can be provided to journal editors to encourage them to improve their policies. Future research should review the degree of transparency of research published in journals to assess compliance with journal policies. Furthermore, the impact of poor transparency and open science practices on individual and societal health outcomes should be studied to demonstrate its real-world consequences. We found that the 19 highly ranked health and medical sciences journals had minimal requirements for transparency and openness standards in their policies. During the COVID-19 pandemic, nominal improvements in the journal policies were observed. As the primary gatekeepers of research and evidence dissemination that impacts individual . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint improved to reflect the ongoing need for transparent and open research. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 28, 2022. ; https://doi.org/10.1101/2022.01.26.22269868 doi: medRxiv preprint Reproducible research practices, transparency, and open access data in the biomedical literature Increasing value and reducing waste in research design, conduct, and analysis Mandated data archiving greatly improves access to research data Social scientists' data sharing behaviors: Investigating the roles of individual motivations, institutional pressures, and data repositories What is Open Science? Introduction Why researchers should share their analytic code 1,500 scientists lift the lid on reproducibility Why most published research findings are false The reproducibility crisis in science: A statistical counterattack Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing Open science saves lives: lessons from the COVID-19 pandemic COVID-19 resources for librarians, campuses and health professionals GitHub: Where the world builds software PROSPERO International prospective register of systematic reviews Open Science Badges enhance openness, a core value of scientific practice Data sharing by scientists: practices and perceptions Open science challenges, benefits and tips in early career and beyond Reducing bias and improving transparency in medical research: a critical overview of the problems, progress and suggested next steps Growth rates of modern science: A bibliometric analysis based on the number of publications and cited references Preregistration of Analyses of Preexisting Data Addressing selective reporting of experiments through predefined exclusion criteria Registered reports: an early example and analysis Promoting an open research culture The Status of Trial Registration Eleven Years after the ICMJE Policy Limited engagement with transparent and open science standards in the policies of pain journals: a cross-sectional evaluation Principles of open, transparent and reproducible science in author guidelines of sleep research and chronobiology journals Evaluation of Journal Policies to Increase Promotion of Transparency and Openness in Sport Science Research Transparency during global health emergencies Transparency and open science standards in the policies of medical and health science journals Transparency and open science standards in the policies of medical and health science journals The TOP Guidelines were created by journals, funders, and societies to align scientific ideals with practices Guidelines for Transparency and Openness Promotion (TOP) in Journal Policies and Practices "The TOP Guidelines" Version 1.0.1. Open Sciences Framework Disclosure of Interest Transparency and open science standards in the policies of medical and health science journals: georgiarichards/TOP_medjournals Transparency and open science standards in the policies of medical and health science journals Research transparency promotion by surgical journals publishing randomised controlled trials: a survey Badges to Acknowledge Open Practices: A Simple, Low-Cost, Effective Method for Increasing Transparency Data-sharing recommendations in biomedical journals and randomised controlled trials: an audit of journals following the ICMJE recommendations COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time The reproducibility "crisis Sample Implementation of Guidelines for Transparency and Openness Promotion (TOP) in TOP Factor -Transparency and Openness Promotion 19 Data Sharing | NIH: National Institute of Allergy and Infectious Diseases Variant Therapeutic in vivo Variant Studies Global coalition to accelerate COVID-19 clinical research in resource-limited settings